[{"NetIncomeLoss_1_Q2_USD":-50288562.0,"GeneralAndAdministrativeExpense_2_Q2_USD":26729578.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14410865.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":48860930.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":48741296.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":13472966.0,"RestrictedCashCurrent_0_Q2_USD":4500000.0,"InterestPaidNet_2_Q2_USD":10833.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-486544.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-456869124.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":590163.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1485519.0,"AssetsCurrent_0_Q2_USD":627733962.0,"LongTermDebt_0_Q2_USD":1000000.0,"ContractWithCustomerLiability_0_Q2_USD":37013663.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3613289.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":8093981.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1487239.0,"CommonStockSharesIssued_0_Q2_shares":48994869.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":551849110.0,"Assets_0_Q2_USD":644026885.0,"ShareBasedCompensation_2_Q2_USD":24895874.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4564666.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":362979.0,"DepreciationAndAmortization_1_Q2_USD":1165385.0,"DepreciationAndAmortization_2_Q2_USD":2313395.0,"MarketableSecuritiesCurrent_0_Q2_USD":551849110.0,"OperatingLeaseLiability_0_Q2_USD":4617715.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":674856.0,"ResearchAndDevelopmentExpense_2_Q2_USD":77877689.0,"ResearchAndDevelopmentExpense_1_Q2_USD":43010807.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4980694.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-1047340.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-243789.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-5386874.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1484462.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1236657.0,"CommonStockValue_0_Q2_USD":48995.0,"Revenues_2_Q2_USD":11083783.0,"Revenues_1_Q2_USD":5544418.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":9129676.0,"OtherReceivablesNetCurrent_0_Q2_USD":7415611.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":8093981.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-92300193.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-50532351.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2442944.0,"OtherAssetsNoncurrent_0_Q2_USD":28777.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":48726443.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3396563.0,"Liabilities_0_Q2_USD":61079711.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-243789.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-1047340.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":37000000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-8075431.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":11100000.0,"OperatingIncomeLoss_1_Q2_USD":-51877254.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":24895874.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":14568216.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-86371646.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1333080.0,"LiabilitiesCurrent_0_Q2_USD":41820346.0,"AccountsPayableCurrent_0_Q2_USD":4975367.0,"NonoperatingIncomeExpense_2_Q2_USD":2270631.0,"NonoperatingIncomeExpense_1_Q2_USD":1588692.0,"InterestExpense_2_Q2_USD":24375.0,"InterestExpense_1_Q2_USD":8125.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":53226443.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15242798.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8093981.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":-28043.0,"LongTermDebtNoncurrent_0_Q2_USD":1000000.0,"InterestExpenseDebt_2_Q2_USD":24375.0,"InterestExpenseDebt_1_Q2_USD":8125.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"AdditionalPaidInCapital_0_Q2_USD":1166526486.0,"OperatingLeasePayments_2_Q2_USD":602149.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":46240.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":296432.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":11699480.0,"NetIncomeLoss_2_Q2_USD":-91252853.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_Q2_pure":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":103619.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":8430778.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":11075430.0,"InvestmentIncomeInterest_2_Q2_USD":810544.0,"InvestmentIncomeInterest_1_Q2_USD":360160.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":22150861.0,"OperatingLeaseCost_2_Q2_USD":689606.0,"OperatingLeaseCost_1_Q2_USD":348154.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":644026885.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4700704.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":188758.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":20130258.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1221152.0,"OperatingExpenses_2_Q2_USD":104607267.0,"OperatingExpenses_1_Q2_USD":57421672.0,"OperatingIncomeLoss_2_Q2_USD":-93523484.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3189055.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.87,"ProfitLoss_2_Q2_USD":-91252853.0,"StockholdersEquity_0_Q2_USD":582947174.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":14862802.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1456928.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":552335654.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-2673364.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-583141763.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-535146789.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1000000.0,"CommonStockSharesOutstanding_0_Q2_shares":48994869.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":537970196.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.03,"AccruedProfessionalFeesCurrent_0_Q2_USD":1320597.0,"Ticker":"ARVN","CIK":"1655759","name":"ARVINAS, INC.","OfficialName":"Arvinas Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3525475441.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]